Patents (representative of over 100 patents issued)
- United States Patent: Treatment of Urinary Incontinence
- United States Patent: Methods of Alleviating Symptoms Associated with Diabetes and Diabetic Neuropathy Comprising Administration of Low Levels of Antibodies
- United States Patent: Method for Treatment of Symptoms of Central Nervous System Disorders
- United States Patent: Method for Treating Respiratory Distress by Sublingual Administration of DNA
- United States Patent: Treatment of Cardiomyopathy
Peer-Reviewed Publications
"Streptolysin O enhances keratinocyte migration and proliferation and promotes skin organ culture wound healing in vitro." Tomic-Canic M, Mamber, SW, Stojadinovic O, Lee B, Radoja N, McMichael, J. Wound Repair and Regeneration 15(1):71-79, 2007.
"The use of streptolysin O for the treatment of scars, adhesions and fibrosis: Initial investigations using murine models of scleroderma." Mamber SW, Long V, Rhodes RG, Pond-Tor S, Wheeler LR, Fredericks K, Vanscoy B, Sauniere J.-F, Steinschneider R, Laurent J.-C, and McMichael J. Nonlinearity in Biology, Toxicology and Medicine 2004 Apr-Jun;2(2):67-87.
"A Trial Study: The Effect of Low Dose Human Chorionic Gonadotropin on the Symptoms of Benign Prostatic Hyperplasia," Michael F. Godschalk, Kenneth A. Unice, Donald Bergner, P. Gary Katz, Thomas Mulligan, and John McMichael. The Journal of Urology, Volume 170, 1264-1269, 2003.
"Enhancement of radiosensitivity of the MCF-7 breast cancer cell line with human chorionic gonadotropin," Sunthorn Pond-Tor, Ryan G. Rhodes, Paul E. Dahlberg, John T. Leith, John McMichael, and Albert E. Dahlberg. Breast Cancer Research and Treatment, Volume 72: 45-51, 2002.
Presentations
Paper presented at the Fifth International Conference on Non-Linear Dose-Response Relationships in Biology, Toxicology, and Medicine, June 6-8 2006, at the University of Massachusetts, Amherst, MA.:
- Streptolysin O Enhances Keratinocyte Migration and Proliferation, and Promotes Skin Organ Culture Wound Healing
Paper presented at the Third International Conference on Non-Linear Dose-Response Relationships in Biology, Toxicology, and Medicine, June 8-10, 2004, at the University of Massachusetts, Amherst, MA.:
- The Use of Low Dose Thimerosal for the Treatment of Type A Influenza.